Aberdeen’s Akus on the struggles facing healthcare, biotech investors
Jason Akus, Head of Healthcare Investing for Aberdeen Investments, says that current conditions for healthcare and biotech investing are making for "one of the most challenging, difficult and dislocated environments I've seen." While trades in technology, artificial intelligence and...
David Tepper: Closed-end funds remain an investment bargain
David Tepper of Tepper Capital Management in San Francisco explains why he uses closed-end funds almost exclusively in his client portfolios, noting that in today's market conditions there are plenty of opportunities to build a well-diversified portfolio at a discount...
ClearBridge’s Vanderlee: Dividend stocks are a bargain in income-starved market
Peter Vanderlee of ClearBridge Investments, co-manager of the LMP Capital and Income Fund, says that the stock market's recovery back to record-high levels hasn't made dividend stocks overpriced because much of the move has been in stocks that don't make distributions..


